SlidesetViral Hepatitis and Liver DiseaseNational Programs - Australia | Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseProgress towards elimination in the Australian prison sector | Andrew Lloyd, MBBS, MD, FRACP, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseWHO Guidelines and Policies of testing | Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseChallenges in Monitoring (POC) | Isabelle Andrieux-MeyerView Slideset
SlidesetViral Hepatitis and Liver DiseaseCreating awareness and sharing the knowledge | Anya SarangView Slideset
SlidesetViral Hepatitis and Liver DiseaseGlobal Injection Safety Campaign and Prevention Strategies | Arshad Altaf, MD, MBBSView Slideset
SlidesetViral Hepatitis and Liver DiseaseVaccine development and results | Andrea Cox, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseMinimising treatment duration and doses | Jordan Feld, MD, MPHView Slideset
SlidesetViral Hepatitis and Liver DiseaseCommunity and harm reduction response to infection and reinfection | Eberhard SchatzView Slideset
SlidesetViral Hepatitis and Liver DiseaseFinancial models for high- and low income countries | Pieter WalhofView Slideset
SlidesetViral Hepatitis and Liver DiseaseNational Programs - the Netherlands | Anouk UrbanusView Slideset
SlidesetNational perspectives in Europe - common themes and challenges | Angelos Hatzakis, MD, PhD, MScView Slideset
